Rohto Pharmaceutical Co.,Ltd.

RPHCF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income$42$42$0$0
Dep. & Amort.$13$9$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$4-$9-$0$0
Other Non-Cash-$14-$7$31$27
Operating Cash Flow$37$34$0$0
Investing Activities
PP&E Inv.-$9-$9-$0-$0
Net Acquisitions-$74$0$0-$0
Inv. Purchases-$10-$9-$0-$0
Inv. Sales/Matur.$6$2$0$0
Other Inv. Act.-$2-$0-$13-$16
Investing Cash Flow-$89-$16-$13-$16
Financing Activities
Debt Repay.$32-$1-$10$8
Stock Issued$0$0$0$0
Stock Repurch.-$5$0$0$0
Dividends Paid-$7-$5-$5-$3
Other Fin. Act.$15-$7-$2-$1
Financing Cash Flow$35-$14-$16$3
Forex Effect$3$5$5$4
Net Chg. in Cash-$13$9$7$19
Supplemental Information
Beg. Cash$87$78$1$0
End Cash$73$87$1$1
Free Cash Flow$26$25$0$0